These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35484698)

  • 1. Spatial analysis of tumor-infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma.
    Xu H; Cha YJ; Clemenceau JR; Choi J; Lee SH; Kang J; Hwang TH
    J Pathol Clin Res; 2022 Jul; 8(4):327-339. PubMed ID: 35484698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer.
    Liu L; Long M; Su S; Wang L; Liu J
    PeerJ; 2024; 12():e16747. PubMed ID: 38223758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral spatial heterogeneity of tumor-infiltrating lymphocytes is a significant factor for precisely stratifying prognostic immune subgroups of microsatellite instability-high colorectal carcinomas.
    Jung M; Lee JA; Yoo SY; Bae JM; Kang GH; Kim JH
    Mod Pathol; 2022 Dec; 35(12):2011-2022. PubMed ID: 35869301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Tumor-Infiltrating Lymphocytes Determined Using LinkNet on Colorectal Cancer Pathology Images.
    Liu A; Li X; Wu H; Guo B; Jonnagaddala J; Zhang H; Xu S
    JCO Precis Oncol; 2023 Feb; 7():e2200522. PubMed ID: 36848612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
    Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
    World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of machine learning-based tumor-infiltrating lymphocytes analysis in colorectal cancer: Overview of techniques, performance metrics, and clinical outcomes.
    Kazemi A; Rasouli-Saravani A; Gharib M; Albuquerque T; Eslami S; Schüffler PJ
    Comput Biol Med; 2024 May; 173():108306. PubMed ID: 38554659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours.
    Linder N; Taylor JC; Colling R; Pell R; Alveyn E; Joseph J; Protheroe A; Lundin M; Lundin J; Verrill C
    J Clin Pathol; 2019 Feb; 72(2):157-164. PubMed ID: 30518631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy.
    Cha YJ; Park EJ; Baik SH; Lee KY; Kang J
    Sci Rep; 2019 Aug; 9(1):11617. PubMed ID: 31406179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    Iseki Y; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    PLoS One; 2018; 13(4):e0192744. PubMed ID: 29698402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.
    Swisher SK; Wu Y; Castaneda CA; Lyons GR; Yang F; Tapia C; Wang X; Casavilca SA; Bassett R; Castillo M; Sahin A; Mittendorf EA
    Ann Surg Oncol; 2016 Jul; 23(7):2242-8. PubMed ID: 26965699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence-assisted analysis for tumor-immune interaction within the invasive margin of colorectal cancer.
    Ye Y; Wu X; Wang H; Ye H; Zhao K; Yao S; Liu Z; Zhu Y; Zhang Q; Liang C
    Ann Med; 2023 Dec; 55(1):2215541. PubMed ID: 37224471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
    Hida AI; Watanabe T; Sagara Y; Kashiwaba M; Sagara Y; Aogi K; Ohi Y; Tanimoto A
    Breast Cancer Res Treat; 2019 Nov; 178(2):283-294. PubMed ID: 31402409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased number of forkhead box P3+ tumor-infiltrating lymphocytes correlates with high preoperative albumin level and better survival in patients with stage II or III colorectal cancer.
    Wang DL; Liu YY; Gu YL; Qin Y; Ji HF; Wu LH; Qi N; Su D; Huang SH; Zhang YQ
    Tumour Biol; 2015 Jul; 36(7):5407-14. PubMed ID: 25697896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial).
    Googe PB; Theocharis S; Pergaris A; Li H; Yan Y; McKenna EF; Moschos SJ
    Curr Probl Cancer; 2022 Jun; 46(3):100862. PubMed ID: 35398635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma.
    Shaban M; Khurram SA; Fraz MM; Alsubaie N; Masood I; Mushtaq S; Hassan M; Loya A; Rajpoot NM
    Sci Rep; 2019 Sep; 9(1):13341. PubMed ID: 31527658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.